foxo4 dri senolytic peptide human trial 2024 2025 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Senotherapy for chronic lung disease
Description
Ideal for weakness, weight loss and poor performance
Available from: Jain K, Murphy PN, Clough TM
doi: 10.1007/s10534-014-9758-z
Modulation of tight junction structure and function by kinases and phosphatases targeting occludin
